-
Samuel Achilefu, Ph.D.
- Molecular optical and multimodal imaging and monitoring treatment response of diseases
-
Luis F.Z. Batista, Ph.D.
- Understanding the importance of telomerase in human stem and progenitor cell function and regulation
-
Kendall J. Blumer, Ph.D.
- Tumor cell signal transduction and drug development
-
Ron Bose, M.D., Ph.D.
- Genomics and Cell Signaling in Breast Cancer
-
Yin Cao, Sc.D., MPH
- Novel lifestyle, microbial, and genetic risk factors for gastrointestinal cancers leveraging large-scale clinical and population-based cohorts with deep genetic and phenotypic data
-
Grant Challen, Ph.D.
- Understanding the genetic and epigenetic mechanisms that regulate normal and leukemic stem cells
-
Aadel A. Chaudhuri, M.D., Ph.D.
- Liquid biopsy cancer detection
-
Milan G. Chheda, M.D.
- Cancer stem cells, oncolytic viruses, and functional genomics of brain tumors
-
Jaebok Choi, Ph.D.
- Understanding T cells and immunoregulatory networks in GvHD and GvL for the treatment of hematopoietic malignancies.
-
Kyunghee Choi, Ph.D.
- Hematopoietic and Vascular Development and Regeneration
-
Matt Christopher, M.D., Ph.D.
- Improve outcomes for patients with acute myeloid leukemia (AML) and other hematopoietic malignancies utilizing genomic and molecular biology techniques
-
Matthew A. Ciorba, M.D.
- Tryptophan metabolism and probiotic bacteria as modifiers of intestinal cancer and inflammation
-
Graham A. Colditz, M.D., Dr.P.H.
- Causes and prevention of chronic disease, particularly among women
-
David G. DeNardo, Ph.D.
- Molecular Mechanisms of Immune Regulation of Tumor Progression.
-
Carl DeSelm, M.D., Ph.D.
- Dr. DeSelm clinically focuses on treating lymphoma, and is actively developing novel CAR T cell approaches to treating solid tumors, including lymphoma, pancreatic cancer and glioblastoma.
-
Katherine C. Fuh, M.D., Ph.D.
- Identifying pathways involved in metastasis in the context of incorporating the tumor microenvironment of ovarian cancer
-
Abby M. Green, MD
- The etiology of genome instability in pediatric cancers and the resulting genome-protective responses, also called DNA damage responses, that are activated.
-
Malachi Griffith, Ph.D.
- Improving our understanding of human disease biology and the development of personalized medicine strategies using genomics and informatics technologies
-
Obi L. Griffith, Ph.D.
- Development of personalized medicine strategies for cancer using genomic technologies
-
David H. Gutmann, M.D., Ph.D.
- Leveraging neurogenetic disorders to study normal brain development, cancer, and behavior
-
Dennis E. Hallahan, M.D.
- The mechanisms of cell death in normal tissues during cancer therapy
-
Jason M. Held, Ph.D.
- Redox biochemistry in cell signaling and disease, Proteomics
-
Angela Hirbe, M.D., Ph.D.
- Utilization of genomic information from sarcomas to better understand the pathogenesis of these tumors and to identify biomarkers and therapeutic targets for these aggressive cancers.
-
Chyi-Song Hsieh, M.D., Ph.D.
- Understanding T cell tolerance to self and non-self
-
Joseph Ippolito, M.D., Ph.D.
- Sex differences in cancer metabolism
-
James W. Janetka, Ph.D.
- The rational structure-based drug design and synthesis for cancer and infectious disease
-
Charles Kaufman, MD, Ph.D.
- Understanding and modifying the mechanisms controlling the onset of melanoma cancer by integrating zebrafish models and human disease
-
Albert H. Kim, M.D., Ph.D.
- Genetic and epigenetic changes that drive malignant behavior in brain tumors
-
Eynav Klechevsky, Ph.D.
- Human Dendritic Cell biology and Novel vaccines
-
Kian Lim, M.D., Ph.D.
- Understanding the role of inflammation in gastrointestinal cancers
-
Daniel C. Link, M.D.
- Molecular regulation of normal and malignant hematopoiesis
-
Gregory D. Longmore, M.D.
- Cell Motility and Cancer Metastasis
-
Jeffrey Magee, M.D., Ph.D.
- Developmental context and genetic variation as underlying mechanisms of childhood cancer
-
Christopher Maher, Ph.D.
- Understanding the role of long non-coding RNAs in solid tumors
-
Ben Major, Ph.D.
- Studying how perturbation of specific signal transduction pathways contributes to the initiation, progression and dissemination of cancer
-
Stephanie Markovina, M.D., Ph.D
- Studies novel metrics to serve dual purpose as biomarkers for prognosis and response to radiation therapy, as well as therapeutic targets for human solid tumors such as cervical and anal cancers.
-
Jason C. Mills, M.D., Ph.D.
- Developmental, molecular, and cellular biology of gastrointestinal epithelial stem cells and gastric cancer
-
Shamim Mollah, Ph.D.
- Interpret and distill the complexity of cancer and other rare diseases through integration of large scale multi-omics data
-
Nima Mosammaparast, M.D., Ph.D.
- Understanding the molecular mechanisms of the DNA damage response and DNA repair in human cells
-
Stephen Oh, M.D., Ph.D.
- Mechanisms of dysregulated signaling in blood cancers
-
Gary Patti, Ph.D.
- To understand the metabolic crosstalk between cells and tissues in disease models such as cancer by using isotopes and metabolomics
-
Jacqueline Elise Payton, M.D., Ph.D.
- Epigenomic aberrations in B cell lymphomas and their impact on gene regulation
-
Sid Puram, M.D., Ph.D.
- Understanding the role of tumor heterogeneity in cancer biology, including its contributions to cancer development, growth, metastasis, and treatment resistance mechanisms, in order to translate these insights into new diagnostics and novel therapeutics
-
Lee Ratner, M.D., Ph.D.
- Molecular biology and pathogenesis of HIV and HTLV
-
Joshua B. Rubin, M.D., Ph.D.
- Molecular mechanisms in pediatric brain tumorigenesis
-
Robert D. Schreiber, Ph.D.
- Cytokine receptor signaling and immunological protection against tumor development
-
Julie Schwarz, M.D., Ph.D.
- Molecular imaging in gynecologic cancers, biomarker development, Development of novel agents for the early detection of metastic disease
-
Jieya Shao, Ph.D.
- Understanding the "moonlighting" functions and therapeutic potential of novel cancer targets
-
Monica Shokeen, Ph.D.
- Development and evaluation of small- and macro-molecular agents for multi-modal molecular imaging of cancer and cardiovascular diseases
-
Nathan Singh, M.D., M.S.
- Understanding how synthetic antigen receptors direct T cell function and dysfunction in the treatment of blood cancers
-
George P. Souroullas, Ph.D.
- Understand how epigenetic mechanisms and chromatin dynamics contribute towards the development of cancer.
-
David H. Spencer, M.D., Ph.D.
- My research program studies epigenetic gene regulation in cancer, with a specific emphasis on understanding how mutations in acute myeloid leukemia (AML) perturb the epigenome to alter gene expression and cause leukemia.
-
Sheila A. Stewart, Ph.D.
- Examining the role the tumor microenvironment plays in immune modulation, tumor development, metastasis and dormancy
-
Adetunji T. Toriola, M.D., Ph.D.
- Associations of metabolic imbalance, inflamation with cancer etiology and survival
-
Brian Van Tine, M.D., Ph.D.
- Understanding the metabolism of sarcomas for therapeutic development
-
Alessandro Vindigni, Ph.D.
- The mechanisms of DNA replication and repair and on the possible strategies to target these mechanisms for cancer treatment
-
Matthew J. Walter, M.D.
- Genetics and genomics of blood cancer: mutation discovery and mouse models
-
Jason D. Weber, Ph.D.
- Role of tumor suppressors and oncogenes in growth control
-
Katherine N. Weilbaecher, M.D.
- Molecular mechanisms through which tumor cells metastasize to bone
-
John Welch, M.D., Ph.D.
- Leukemic alternations of normal hematopoietic self-renewal and differentiation.
|
|